Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

45.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
45.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

47.0K
VSEPR Theory for Determination of Electron Pair Geometries
47.0K
Methods of Medium Optimization01:28

Methods of Medium Optimization

45
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
45
Synthetic Biology02:55

Synthetic Biology

5.8K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.8K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Blood-Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal Delivery.

Advanced healthcare materials·2026
Same author

Malaria in children aged <6 months: a narrative review of current evidence, recommendations and practice gaps.

Tropical medicine and health·2026
Same author

Direct Synthesis of Exfoliated Carbon Nitride Mediated by Sodiated Cellulose Nanocrystals for Photocatalytic and Adsorbent Applications.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Characterization of [<sup><b>18</b></sup>F]PF-NB1 Enantiomers for Imaging NMDA GluN2B Receptors in Nonhuman Primates and Comparison with Analogous <sup><b>18</b></sup>F-labeled Radiotracers.

ACS chemical neuroscience·2025
Same author

Translational molecular imaging and drug development in multiple sclerosis.

Theranostics·2025
Same author

An integrated molecular-thermodynamic framework for analyzing nanobubbles in supersaturated liquids.

RSC advances·2025

Related Experiment Video

Updated: Mar 29, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design.

Khaled Barakat1, Michael Jordy Rojas Ruiz1, Hazem Ahmed1

  • 1Thoth Biosimulations Inc., 4560 Enterprise Square, 10230 Jasper Avenue, Edmonton, Alberta T5J 4P6, Canada.

Journal of Chemical Information and Modeling
|March 27, 2026
PubMed
Summary

AI-MedCraft optimizes multiple drug properties simultaneously using adaptive reinforcement learning. This AI framework effectively handles complex trade-offs in drug discovery, outperforming existing methods in benchmarks.

More Related Videos

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

3.2K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K
Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

3.2K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Area of Science:

  • Computational chemistry
  • Artificial intelligence in drug discovery
  • Molecular design

Background:

  • Drug discovery involves balancing multiple interdependent properties like potency, solubility, and safety.
  • Current computational methods often address these properties sequentially or use simplified scoring, limiting optimization.
  • Existing AI platforms struggle with explicit multiobjective trade-offs in molecular design.

Purpose of the Study:

  • To introduce AI-MedCraft, a novel framework for strategy-driven molecular design.
  • To enable concurrent optimization of multiple objectives within a unified workflow using AI.
  • To address limitations in handling explicit multiobjective trade-offs in computational drug discovery.

Main Methods:

  • AI-MedCraft employs adaptive, Pareto-guided reinforcement learning for concurrent multiobjective optimization.
  • Incorporates physics-aware scoring when structural information is available for binding-competent designs.
  • Evaluated through structure-based benchmarks and case studies in drug redesign.

Main Results:

  • AI-MedCraft demonstrated broader Pareto-front coverage than REINVENT 4 in a BTK inhibitor solubility rescue benchmark.
  • Successfully redesigned Efavirenz to maintain HIV-1 reverse transcriptase engagement while reducing 5-HT2A off-target binding.
  • Achieved superior multiconstraint molecular optimization compared to existing approaches.

Conclusions:

  • AI-MedCraft offers an effective unified workflow for concurrent multiobjective optimization in drug discovery.
  • The framework shows significant advantages in handling complex property trade-offs and improving molecular designs.
  • AI-MedCraft represents a powerful advancement for accelerating rational small-molecule drug design.